Hyun, J., Shin, H., Jang, H., Park, N. Y., Kim, S., & Kim, H. J. (2019). Therapeutic Outcome of Alemtuzumab in Korean Patients with Multiple Sclerosis: 2-Year Follow-Up. J Clin Neurol.
Citação norma ChicagoHyun, Jae-Won, Hyun-June Shin, Hyunmin Jang, Na Young Park, Su-Hyun Kim, and Ho Jin Kim. "Therapeutic Outcome of Alemtuzumab in Korean Patients With Multiple Sclerosis: 2-Year Follow-Up." J Clin Neurol 2019.
Deismireacht MLAHyun, Jae-Won, et al. "Therapeutic Outcome of Alemtuzumab in Korean Patients With Multiple Sclerosis: 2-Year Follow-Up." J Clin Neurol 2019.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.